Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: A validation study

Heart

Volumn 94, Issue 1, 2008, Pages 34-39

  Hippisley Cox, J ^a   Coupland, C ^a   Vinogradova, Y ^a   Robson, J ^b   Brindle, P ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Avon Primary Care Research Collaborative   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ALGORITHM; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FRAMINGHAM SCORE; GENERAL PRACTICE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QRISK SCORE; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; VALIDATION STUDY;

ADULT; AGED; ALGORITHMS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 37749048943     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.134890     Document Type: Article

References (18)

1. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136..
2. Anderson KM, Odell PM, Wilson PWF, et al. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-8.
3. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to the cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007;2:172-6.
4. Hippisley-Cox JCC, Vinogradova Y, Robson J, et al. QRISK: authors' response. BMJ 2007. Available at: http://www.bmj.com/cgi/ eletters/335/7611/136 (accessed 19 October 2007).
5. Gail M, Pfeiffer R. On evaluating models of absolute risk. Biostatistics 2005;6:227-39.
6. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Stat Med 2004;23:723-48.
7. Royston P. Explained variation for survival models. The Stata Journal 2006;6:1-14.
8. JBS2. Joint British Society Guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl 5):1-52.
9. 8a. van der Heijden G, Donders A, Stijnen T, et al. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 2006;59:1102-9.
10. De Becker G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-10.
11. Department of Health. Tackling health inequalities: a programme for action. London: Deparment of Health, 2003:83.
12. Brindle P, McConnachie A, Upton M, et al. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract 2005;55:838-45.
13. Victora C, Vaughan J, Barros F, et al. Explaining trends in inequities: evidence from Brazilian child health studies. Lancet 2000;356:1093-8.
14. Lloyd Jones X, Lloyd-Jones D, Nam B, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004;291:2204-11.
15. Nilsson P, Nilsson J, Berglund G. Family burden of cardiovascular mortality: risk implications for offspring in a national register linkage study based upon the Malmo Preventive Project. J Intern Med 2004;255:229-35.
16. Ward S, LLoyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11:1-160.
17. North of England Hypertension Guideline Development Group. Essential hypertension: managing adult patients in primary care (NICE guideline). Available at http://www.guideline.gov/summary/summary.aspx? doc_id=5635&nbr=3796 (accessed 19 October 2007).
18. NICE. Statins for the prevention of cardiovascular events in patients at increased risk of developing cardiovascular disease or those with established cardiovascular disease guidance type: Technology appraisal. In: Excellence NlfHaC, ed. 2006. Available at http://www.nice.org.uk/TA094 (accessed 19 October 2007).